Fuad Mirzayev
- Infectious Diseases top 5%
- Tuberculosis Research and Epidemiology 22
- Antimicrobial Resistance in Staphylococcus 2
- Epidemiology top 10%
- Pneumocystis jirovecii pneumonia detection and treatment 7
- Pneumonia and Respiratory Infections 6
- Mycobacterium research and diagnosis 4
- Molecular Medicine top 10%
-
- Diagnosis and treatment of tuberculosis 4
- Infectious Diseases and Tuberculosis 3
-
- Health Systems, Economic Evaluations, Quality of Life 4
- Co-authors
- Matteo ZignolLinh NguyenErnesto JaramilloMedea GegiaDennis FalzonKatherine FloydKarin WeyerMario Raviǵlione
- Journals
- Nature Communications (1 paper)SHILAP Revista de lepidopterología (1 paper)Annals of Internal Medicine (1 paper)
- Partner nations
- SwitzerlandUnited StatesItaly
In The Last Decade
Fuad Mirzayev
24 papers receiving 678 citations
Hit Papers
Peers
Comparison fields: 5 of 88
- Infectious Diseases 543
- Epidemiology 386
- Applied Microbiology and Biotechnology 16
- Molecular Medicine 35
- Surgery 215
Countries citing papers authored by Fuad Mirzayev
This map shows the geographic impact of Fuad Mirzayev's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fuad Mirzayev with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fuad Mirzayev more than expected).
Fields of papers citing papers by Fuad Mirzayev
This network shows the impact of papers produced by Fuad Mirzayev. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fuad Mirzayev. The network helps show where Fuad Mirzayev may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Fuad Mirzayev, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 2 | |
| 3 | Multidrug-resistant tuberculosisbreakdown → | 2024 | 70 |
| 4 | 2024 | 6 | |
| 5 | 2023 | 15 | |
| 6 | 2023 | 19 | |
| 7 | 2023 | 16 | |
| 8 | 2023 | 1 | |
| 9 | 2022 | 5 | |
| 10 | 2021 | 18 | |
| 11 | 2021 | 41 | |
| 12 | 2020 | 16 | |
| 13 | 2020 | 155 | |
| 14 | 2020 | 3 | |
| 15 | 2019 | 2 | |
| 16 | 2017 | 8 | |
| 17 | 2016 | 2 | |
| 18 | 2014 | 102 | |
| 19 | 2012 | 167 | |
| 20 | 2011 | 38 |
About Fuad Mirzayev
Fuad Mirzayev is a scholar working on Infectious Diseases, Epidemiology and Pharmacy, having authored 25 papers that have together received 704 indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (22 papers), Pneumocystis jirovecii pneumonia detection and treatment (7 papers), Pneumonia and Respiratory Infections (6 papers), Health Systems, Economic Evaluations, Quality of Life (4 papers), Diagnosis and treatment of tuberculosis (4 papers), Mycobacterium research and diagnosis (4 papers), Infectious Diseases and Tuberculosis (3 papers) and Antimicrobial Resistance in Staphylococcus (2 papers). The work is most often cited by research in Infectious Diseases (543 citations), Epidemiology (386 citations) and Applied Microbiology and Biotechnology (16 citations). Fuad Mirzayev has collaborated with scholars based in Switzerland, United States and Italy. Frequent co-authors include Matteo Zignol, Linh Nguyen, Ernesto Jaramillo, Medea Gegia, Dennis Falzon, Katherine Floyd, Karin Weyer, Mario Raviǵlione, Licé González-Angulo and Kerri Viney. Their work appears in journals such as Nature Communications, SHILAP Revista de lepidopterología and Annals of Internal Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.